MAO-A dysfunctions and aggressive behaviors in patients with ADHD

Human Psychopharmacology

Volumn 23, Issue 5, 2008, Pages 437-

  Angriman, Marco ^a   Cortese, Samuele ^a,b  

^a UNIVERSITY OF VERONA   (Italy)

^b HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; DOPAMINE; NORADRENALIN; AMINE OXIDASE (FLAVIN CONTAINING); SEROTONIN;

AGGRESSION; ATTENTION DEFICIT DISORDER; DISRUPTIVE BEHAVIOR; FEMALE; GENDER BIAS; GENETIC CODE; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; LETTER; MALE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; CHILD; METABOLISM; NOTE; PSYCHOLOGICAL ASPECT;

AGGRESSION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; FEMALE; HUMANS; MALE; MONOAMINE OXIDASE; SEROTONIN;

EID: 48249155772     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.945     Document Type: Letter

References (5)

1. Brookes K, Xu X, Chen W, et al. 2006. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry 11: 934-953.
2. Das M, Bhowmik AD, Sinha S, et al. 2006. MAOA promoter polymorphism and attention deficit hyperactivity disorder (ADHD) in Indian children. Am J Med Genet B Neuropsychiatr Genet 141: 637-642.
3. Ducci F, Enoch MA, Hodgkinson C, et al. 2008. Interaction between a functional MAOA locus and childhood sexual abuse predicts alcoholism and antisocial personality disorder in adult women. Mol. Psychiatry, 13: 334-347.
4. Xu X, Brookes K, Chen CK, Huang YS, Wu YY, Asherson P. 2007. Association study between the monoamine oxidase A gene and attention deficit hyperactivity disorder in Taiwanese samples. BMC Psychiatry 7: 10.
5. Zepf FD, Stadler C, Demisch L, Schmitt M, Landgraf M, Poustka F. 2008. Serotonergic functioning and trait-impulsivity in attention-deficit/ hyperactivity-disordered boys (ADHD): influence of rapid tryptophan depletion. Hum Psychopharmacol 23: 43-51.